Letter to the Editor July 31, 2008

Dr. Rado and Colleagues Reply

Jeffrey T. Rado, MD; Sheila Dowd, PhD; Philip G. Janicak, MD

J Clin Psychiatry 2008;69(7):1191-1192

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We agree with Dr. Kapoor’s assessment regarding thegrowing number of psychiatric and neurologic disorders forwhich transcranial magnetic stimulation (TMS) is proving useful. Of note, the recently published study of TMS was thelargest (N = 302) randomized, sham-controlled trial to demonstrateefficacy in patients with major depression. Further, thetreatment modality was well tolerated by a majority of patients,with a low incidence of side effects and a low discontinuationrate.’ ‹